Santen Pharmaceutical Co Ltd Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Santen Pharmaceutical Co Ltd

Watchlist Manager

Watchlist

Price: 1 645.5 JPY -2.89% Market Closed

Market Cap: ¥530.3B

	Santen Pharmaceutical Co Ltd TSE:4536	JP

Profitability Summary

Santen Pharmaceutical Co Ltd's profitability score is 58/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

59%

Strong 3Y Average Gross Margin

58%

Declining Gross Margin

61% > 59%

Healthy Operating Margin

17%

Sustainable 3Y Average Operating Margin

15%

Operating Margin is Increasing

14% > 17%

Healthy Net Margin

13%

Sustainable 3Y Average Net Margin

10%

Net Margin is Increasing

9% > 13%

Healthy Free Cash Flow Margin

10%

Strong 3Y Average Free Cash Flow Margin

15%

Declining Free Cash Flow Margin

11% > 10%

Positive ROE

13%

Positive 3Y Average ROE

Positive 3Y Average ROIC

11%

ROIC is Increasing

9% > 13%

View All

Hide

Collapse

58 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

59%

Strong 3Y Average Gross Margin

58%

Declining Gross Margin

61% > 59%

Healthy Operating Margin

17%

Sustainable 3Y Average Operating Margin

15%

Operating Margin is Increasing

14% > 17%